Gemtuzumab Ozogamicin Patent Expiration
Gemtuzumab Ozogamicin is Used for treating acute myeloid leukemia. It was first introduced by Wyeth Pharmaceuticals Inc
Gemtuzumab Ozogamicin Patents
Given below is the list of patents protecting Gemtuzumab Ozogamicin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mylotarg | US5773001 | Conjugates of methyltrithio antitumor agents and intermediates for their synthesis |
Jun 30, 2015
(Expired) | Wyeth Pharms Inc |
| Mylotarg | US5767285 | Linkers useful for the synthesis of conjugates of methyltrithio antitumor agents |
Jun 16, 2015
(Expired) | Wyeth Pharms Inc |
| Mylotarg | US5739116 | Enediyne derivatives useful for the synthesis of conjugates of methyltrithio antitumor agents |
Apr 14, 2015
(Expired) | Wyeth Pharms Inc |
| Mylotarg | US5693762 | Humanized immunoglobulins |
Dec 02, 2014
(Expired) | Wyeth Pharms Inc |
| Mylotarg | US5606040 | Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group |
Feb 25, 2014
(Expired) | Wyeth Pharms Inc |
| Mylotarg | US5585089 | Humanized immunoglobulins |
Dec 17, 2013
(Expired) | Wyeth Pharms Inc |
Gemtuzumab Ozogamicin's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List